Multiple Sclerosis Flashcards

1
Q

Definition of multiple sclerosis

A

a chronic progressive inflammatory disease involving damage to the myelin in the brain and spinal cord
- autoimmune disease (genetics, environment, 1st degree relatives)
- range of medical issues (physical function, depression, participation, personal social)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MS characteristics

A

the most common demyelinating nervous system disease to affect young adults
- mean onset 30 yrs old
- 70% onset 20-40 yrs old
- 10-20% after 60 yrs old
- more in females
- genetic predisposition
- triggered by environmental factors (sunshine, vit D, smoking)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MS is a dysfunction of?

A

oligendrocytes
- pro inflammatory agents released by microglial cells cause dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which cells are reactive in MS?

A

T cells
- they are auto reactive in the periphery of the CNS
- T & B cells cross the weakened blood brain barrier
- T cells interact with B cells & make aberrant antibodies that target oligodendrocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gray matter dysfunction in MS

A

gray matter pathology is closely associated with clinical disability than white matter (white matter injury is said to come independently)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epidemiology of MS

A
  • women > men
  • men have a worse prognosis/aggressive disease
  • extreme north/south latitudes
  • least common in warm climates
  • people who migrate from high risk to low risk regions before puberty reduce risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some geography/environmental triggers?

A
  • Epstein Barr virus
  • low vit D levels
  • reduced sunlight exposure
  • more common above the 45° latitude
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Inflammatory demyelination

A

damage to the transmission of nerve impulses
1. inflammation to oligodendrocytes
2. oligodendrocytes demyelinate
3. inflammation subsides and symptoms reduce
4. oligodentrocytes remyelinate
5. more/repeated inflammation causes reduced repairing leading to axonal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does axonal damage equate to?

A

irreversible disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Plaques

A

focal loss of myeline leads to fibrous astrocytes and undergoes gliosis leading to plaques
–> axonal loss is present
50% spinal cord
25% optic nerve
25% brainstem/cerebellum

** plaques are the hallmark of MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MS classification: Relapsing-Remitting

A

(RRMS) unpredictable attacks which may or may not leave permanent deficits followed by periods of remission
~ 85% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MS classification: Secondary Progressive

A

(SPMS) initial relapsing remitting that suddenly begins to have decline without periods of remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MS classification: Primary Progressive

A

stead increase in disability without attack, gradual worsening of symptoms that does not respond to treatment prescriptions
–> progressive myelopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MS classification: Benign

A

one occurrence with no reoccurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MS classification: Progressive Relapsing

A

steady decline since onset with superimposed attacks, progressive course with clear relapses
~ 5% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MS Expanded Disability Status Scale 0-4

A

0 = not affected
1 = no disability
2 = minimal disability
3 = moderate disability
4 = relatively severe disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MS Expanded Disability Status Scale 5-9

A

5 = disability affects daily routine
6 = assistance required to work
7 = restricted to wheelchair
8 = restricted to bed or wheelchair
9 = confined to bed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diagnosing MS

A

there is no single test, a collection of medical tests to confirm diagnosis (MRI, lumbar puncture)
- 2 lesions in at least 2 separate areas of the brain, spinal cord, or optic nerve
AND
- evidence of damage at 2 different points in time
AND
- rule out other diagnoses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Differential diagnosis for MS

A
  • chronic low back pain (common 1st issue)
  • fibromyalgia
  • cervical spondyosis
  • herniated disc
  • mitochondrial disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Suspected MS symptom picture

A

significant lapse between the initial s/s (flares) and an additional episode of MS (can sometimes be years)
- some people may have a clinical isolated symptom (one event) and no other signs after that

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lumbar puncture: MS

A

the basic protein found in the CSF will be elevated during acute exacerbations of MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Visual evoked potential (VEP)

A

tests that measure the electrical activity of the brain (optic nerve) in response to stimulation of visual nerve pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the initial symptoms of MS?

A
  • females in their 20s
  • usually transient
  • fatigue
  • visual disturbances (double vision)
  • paresthesias, numbness, weakness, pins/needles (usually accompanied by LBP)
  • pain in B LEs (sudden and spontaneous electrical shock)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are some red flags in terms of MS symptoms?

A

double vision

pain in B LEs with a sudden electrical shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

S/S of MS flare/relapse/exacerbation

A
  • numbness/tingling
  • fatigue
  • visual changes
  • weakness
  • changes in gait
  • brain fog
  • tremors
  • incontinence

** last longer than 24 hours (days, weeks, months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Disease pathway of MS

A
  1. initial diagnosis
  2. exacerbation
  3. period of remission
  4. disease of management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Exacerbation and damage

A

the longer the length of an exacerbation the more damage may occur

28
Q

Pseudo exacerbation

A

brought on by stress, over exertion, or heat
- causes fatigue, brain fog, pain
- will resolve in less than 24 hours on its own
- DOES NOT MEAN THAT THE NERVOUS SYSTEM IS UNDERGOING DAMAGE

29
Q

Fatigue

A

a subjective response perceived by an individual

30
Q

Primary fatigue

A

autoimmune, lassitude (lethargy)

31
Q

Indirect fatigue

A

medications that cause sleep

32
Q

Neurologic fatigue

A

spasms, weakness, heat exposure, energy failure

33
Q

Mitochondrial genetic variants and MS fatigue

A

deficient mitochondrial metabolism may generate more reactive oxygen specific (ROS) that wreak havoc in cells
–> mitochondrial injury and subsequent energy failure are key factors in the induction of demyelination and neurodegeneration

34
Q

Fatigue in MS

A

greater exposure to stress (deadlines at work, family conflict) and low mood were associated with higher fatigue levels while positive moods are associated with lower levels of fatigue
* increased fatigue was associated with recent physical activity in people with MS

35
Q

Uhtoff phenomenon

A

increase in core body temp (70% of people with MS experience)
- physical exertions, hot water, warm temps are all correlated with fatigue
- temporary symptoms usually don’t increase MS symptoms
- rapidly reversed with symptoms are removed

36
Q

Motor system in MS

A

weakness (brain and spinal cord)
- mono, hemi, quad paresis
- deconditioning
- dysarthria

ataxia (80% of people have it)
- cerebellar
- dysmetria or dysdiadochokinesia
- tremor

37
Q

Spasms

A

sudden contractions/jumping of extremities (occurs in spinal cord pathology)
- can be flexor or extensor
- LE > UE

38
Q

Hypertonicity/spasticity in MS

A

velocity sensitive resistance to muscle stretch, highly correlated with reduced function and QOL
- spasticity seen with position changes, noxious stimuli, or physiologic stress
- may be seen with increased pain, cold weather, tight clothing, or increased body temps

39
Q

What can spasticity lead to?

A

contractures, skin breakdown, pain/sleep disturbances

40
Q

Acute neuropathic pain

A

brought on by demyelination of sensory neurons (anteriolateral tract)

41
Q

Trigeminal neuralgia

A

stabbing pain in the face or jaw, pain is not constant

42
Q

Lhermitte’s sign

A

brief stabbing electrical shock through the spinal cord

43
Q

Chronic neuropathic pain

A
  • brought on by stress (disease stress), fatigue, illness, or overheating
  • patient may feel dysesthesias or pruritis
44
Q

Dysesthesia

A

painful sensations of the upper and lower limbs that are burning, lancing, prickling, stabbing, or icy

45
Q

Pruritis

A

a form of dysesthesia (pins and needles), itching, burning, stabbing

46
Q

Musculoskeletal pain

A
  • muscular tightness/loss of ROM
  • spasticity, weakness, abnormal motion
  • compensatory patterns during movement
  • muscular pain from abnormal use or loading
  • muscular fatigue
47
Q

Sensory impairments in MS

A

VISUAL
- optic neuritis (20% will have in the first MS event)
- double vision, blurry, painful eye movements
- visual field loss, color desaturation
- pupillary deficits

SOMATOSENSORY/PROPRIOCEPTIVE
- dysethesias (tingling, vibrations)
- anesthesias
- parasthesias
- vestibular (dizziness/vertigo)

NEUROPATHIC PAIN

48
Q

Gait dysfunction in MS

A

decreased mobility due to other deficits
- spasticity, weakness, sensory loss
- coordination/ataxia
- loss of sensation

49
Q

Postural control and falls in MS

A

complex interaction between sensory inputs, motor output, processing, and context
- leads to fractures from falls

50
Q

What are the three common problems in MS in terms of postural control/falls?

A
  1. delayed response to postural perturbations
  2. increased body sway to quiet standing
  3. inability to move outside of BOS
51
Q

Bowel problems in MS

A

35-58% experience this
- fecal retention
- incontinence
- constipation

52
Q

Bladder problems in MS

A

52-97% experience this
- urinary urgency
- incontinence
- overactive detrusor

53
Q

Psychosocial problems in MS

A

depression is 2-3x more likely compared to other neuro conditions
- associated with lower QOL

54
Q

Cognitive problems in MS

A
  • decreased verbal fluency and verbal memory
  • decreased processing speed
  • decreased executive functioning
55
Q

Cycle of symptoms

A
  • increase in fatigue and depression
  • exercise decreases
  • spasticity and constipation increase
  • bladder problems
  • decrease in sleep
  • decreased cognitive function
56
Q

Disease modifying drugs: relapsing remitting MS

A

prevention of new inflammatory lesion and prevention of the development of secondary progressive MS

57
Q

Disease modifying drugs: secondary and primary MS

A

prevention of loss of nerve fibers (neuroprotection) and allows for remyelination

58
Q

Disease modifying drugs: Ocrevus

A

used in people with relapsing and progressive forms of MS
- 2x/yr
- 10 min IV drug
- suppresses relapse acitivity and MRI lesions in 97% of people in 48 weeks

59
Q

Outcomes of MS

A
  • life expecacntny 6 years earlier than general population (72 women, 68 men)
  • higher mortality risk in patients with primary progressive MS
60
Q

Progression of MS in the field

A
  • it is highly variable
  • disease modifying therapy has reduced level of burden and progression
  • research on progressive forms
  • there has been earlier diagnosis and prompt medical intervention
61
Q

Clinical picture: clinical isolated syndrome

A
  • aucte/subacute onset of a monophasic episode suggestive of MS (longer than 24 hrs and affects optic nerve, brainstem, or spinal cord)
  • 30-70% of patients will develop MS
  • patients with optic neuritis have higher risk of MS development
  • age of onset 20-45 yrs, more in women
62
Q

Clinical picture: relapsing remitting

A
  • relapses over days to weeks with complete or partial remissions over months to years (~85% of cases)
  • age of onset 20-30 yrs, more in women
63
Q

Clinical picture: progressive

A

progressive accumulation of disability after initial relapsing

64
Q

Clinical picture: secondary progressive

A

~75% of relapsing remitting case within 15 years of initial diagnosis will develop this

65
Q

Clinical picture: primary progressive

A
  • steady functional worsening from the onset of disease
  • ~15% of cases
  • later onset than relapsing remitting
  • more in female
66
Q

SUMMARY: MS

A
  • progressive autoimmune CNS disease
  • myelin, spinal cord, cerebellum, brain
  • variable course and presentation
  • no cure, reduce amount of attacks
67
Q

SUMMARY: functional impairments

A
  • all facets of function and mobility
  • progressive loss of function
  • motor, cognitive, integumentary systems affected
  • risk for secondary complications from lack of movement and mobility